Evogene Launches Drug Discovery Programme Targeting Acute GVHD
Evogene aims to develop a potential first-in-class therapy for acute GVHD, a serious complication of stem cell transplantation with limited second-line treatment options.
Targeted Treatments | 29/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy